How big is the ngs based diagnostics market?

Next generation sequencing NGS based diagnostics are the medical devices used for diagnosis of various conditions using advanced generation sequencing platforms.Market Analysis and Insights Global NGS Based Diagnostics MarketThe global NGS Based Diagnostics market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.North America is currently leading the market due to the research and innovations and presence of maximum numbers of players.

BUY CHAPTERS

Global NGS Based Diagnostics Market Insights and Forecast to 2028

Q: Who are the key players in the ngs based diagnostics market?

Some of the key players are Janssen, Roche, Qiagen NV, ThermoFisher Scientific, Oxford Gene Technology, Illumina Inc, Pacific Biosciences, Paradigm Diagnostics, Innogene Kalbiotech, Admera Health, AITbiotech, CENTOGENE, Phalanx Biotech Group, iGenomX, China, India, Others.

Code: QYRE-Auto-9T1976

Report

February 2022

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Janssen

Roche

Qiagen NV

ThermoFisher Scientific

Oxford Gene Technology

Illumina Inc

Pacific Biosciences

Paradigm Diagnostics

Innogene Kalbiotech

Admera Health

AITbiotech

CENTOGENE

Phalanx Biotech Group

iGenomX

China

India

NGS Based Diagnostics Market

Next generation sequencing (NGS) based diagnostics are the medical devices used for diagnosis of various conditions using advanced generation sequencing platforms.

The global NGS Based Diagnostics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

North America is currently leading the market due to the research and innovations and presence of maximum numbers of players. Europe is following America. Rising caseload of cancer, incidence of drug-resistant infectious diseases in Asian and African countries have created a huge demand of such technologies. Hence, market will grow at a fast pace in these regions.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NGS Based Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NGS Based Diagnostics market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NGS Based Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NGS Based Diagnostics market.

NGS Based Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global NGS Based Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

By Type

DNA Sequencing
RNA Sequencing
Whole Genome Sequencing
Whole Exome Sequencing
Other

By Application

Hospitals
Clinics
Academics/Research Institutions

Key Type

Janssen
Roche
Qiagen
ThermoFisher Scientific
Oxford Gene Technology
Illumina
Pacific Biosciences
Paradigm Diagnostics
Innogene Kalbiotech
Admera Health
AITbiotech
Centogene
Phalanx Biotech Group
iGenomX

By Region

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global NGS Based Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 DNA Sequencing

1.2.3 RNA Sequencing

1.2.4 Whole Genome Sequencing

1.2.5 Whole Exome Sequencing

1.2.6 Other

1.3 Market by Application

1.3.1 Global NGS Based Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Academics/Research Institutions

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global NGS Based Diagnostics Market Perspective (2017-2028)

2.2 NGS Based Diagnostics Growth Trends by Region

2.2.1 NGS Based Diagnostics Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 NGS Based Diagnostics Historic Market Size by Region (2017-2022)

2.2.3 NGS Based Diagnostics Forecasted Market Size by Region (2023-2028)

2.3 NGS Based Diagnostics Market Dynamics

2.3.1 NGS Based Diagnostics Industry Trends

2.3.2 NGS Based Diagnostics Market Drivers

2.3.3 NGS Based Diagnostics Market Challenges

2.3.4 NGS Based Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top NGS Based Diagnostics Players by Revenue

3.1.1 Global Top NGS Based Diagnostics Players by Revenue (2017-2022)

3.1.2 Global NGS Based Diagnostics Revenue Market Share by Players (2017-2022)

3.2 Global NGS Based Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by NGS Based Diagnostics Revenue

3.4 Global NGS Based Diagnostics Market Concentration Ratio

3.4.1 Global NGS Based Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by NGS Based Diagnostics Revenue in 2021

3.5 NGS Based Diagnostics Key Players Head office and Area Served

3.6 Key Players NGS Based Diagnostics Product Solution and Service

3.7 Date of Enter into NGS Based Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 NGS Based Diagnostics Breakdown Data by Type

4.1 Global NGS Based Diagnostics Historic Market Size by Type (2017-2022)

4.2 Global NGS Based Diagnostics Forecasted Market Size by Type (2023-2028)

5 NGS Based Diagnostics Breakdown Data by Application

5.1 Global NGS Based Diagnostics Historic Market Size by Application (2017-2022)

5.2 Global NGS Based Diagnostics Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America NGS Based Diagnostics Market Size (2017-2028)

6.2 North America NGS Based Diagnostics Market Size by Type

6.2.1 North America NGS Based Diagnostics Market Size by Type (2017-2022)

6.2.2 North America NGS Based Diagnostics Market Size by Type (2023-2028)

6.2.3 North America NGS Based Diagnostics Market Share by Type (2017-2028)

6.3 North America NGS Based Diagnostics Market Size by Application

6.3.1 North America NGS Based Diagnostics Market Size by Application (2017-2022)

6.3.2 North America NGS Based Diagnostics Market Size by Application (2023-2028)

6.3.3 North America NGS Based Diagnostics Market Share by Application (2017-2028)

6.4 North America NGS Based Diagnostics Market Size by Country

6.4.1 North America NGS Based Diagnostics Market Size by Country (2017-2022)

6.4.2 North America NGS Based Diagnostics Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe NGS Based Diagnostics Market Size (2017-2028)

7.2 Europe NGS Based Diagnostics Market Size by Type

7.2.1 Europe NGS Based Diagnostics Market Size by Type (2017-2022)

7.2.2 Europe NGS Based Diagnostics Market Size by Type (2023-2028)

7.2.3 Europe NGS Based Diagnostics Market Share by Type (2017-2028)

7.3 Europe NGS Based Diagnostics Market Size by Application

7.3.1 Europe NGS Based Diagnostics Market Size by Application (2017-2022)

7.3.2 Europe NGS Based Diagnostics Market Size by Application (2023-2028)

7.3.3 Europe NGS Based Diagnostics Market Share by Application (2017-2028)

7.4 Europe NGS Based Diagnostics Market Size by Country

7.4.1 Europe NGS Based Diagnostics Market Size by Country (2017-2022)

7.4.2 Europe NGS Based Diagnostics Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific NGS Based Diagnostics Market Size (2017-2028)

8.2 Asia-Pacific NGS Based Diagnostics Market Size by Type

8.2.1 Asia-Pacific NGS Based Diagnostics Market Size by Type (2017-2022)

8.2.2 Asia-Pacific NGS Based Diagnostics Market Size by Type (2023-2028)

8.2.3 Asia-Pacific NGS Based Diagnostics Market Share by Type (2017-2028)

8.3 Asia-Pacific NGS Based Diagnostics Market Size by Application

8.3.1 Asia-Pacific NGS Based Diagnostics Market Size by Application (2017-2022)

8.3.2 Asia-Pacific NGS Based Diagnostics Market Size by Application (2023-2028)

8.3.3 Asia-Pacific NGS Based Diagnostics Market Share by Application (2017-2028)

8.4 Asia-Pacific NGS Based Diagnostics Market Size by Region

8.4.1 Asia-Pacific NGS Based Diagnostics Market Size by Region (2017-2022)

8.4.2 Asia-Pacific NGS Based Diagnostics Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America NGS Based Diagnostics Market Size (2017-2028)

9.2 Latin America NGS Based Diagnostics Market Size by Type

9.2.1 Latin America NGS Based Diagnostics Market Size by Type (2017-2022)

9.2.2 Latin America NGS Based Diagnostics Market Size by Type (2023-2028)

9.2.3 Latin America NGS Based Diagnostics Market Share by Type (2017-2028)

9.3 Latin America NGS Based Diagnostics Market Size by Application

9.3.1 Latin America NGS Based Diagnostics Market Size by Application (2017-2022)

9.3.2 Latin America NGS Based Diagnostics Market Size by Application (2023-2028)

9.3.3 Latin America NGS Based Diagnostics Market Share by Application (2017-2028)

9.4 Latin America NGS Based Diagnostics Market Size by Country

9.4.1 Latin America NGS Based Diagnostics Market Size by Country (2017-2022)

9.4.2 Latin America NGS Based Diagnostics Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa NGS Based Diagnostics Market Size (2017-2028)

10.2 Middle East & Africa NGS Based Diagnostics Market Size by Type

10.2.1 Middle East & Africa NGS Based Diagnostics Market Size by Type (2017-2022)

10.2.2 Middle East & Africa NGS Based Diagnostics Market Size by Type (2023-2028)

10.2.3 Middle East & Africa NGS Based Diagnostics Market Share by Type (2017-2028)

10.3 Middle East & Africa NGS Based Diagnostics Market Size by Application

10.3.1 Middle East & Africa NGS Based Diagnostics Market Size by Application (2017-2022)

10.3.2 Middle East & Africa NGS Based Diagnostics Market Size by Application (2023-2028)

10.3.3 Middle East & Africa NGS Based Diagnostics Market Share by Application (2017-2028)

10.4 Middle East & Africa NGS Based Diagnostics Market Size by Country

10.4.1 Middle East & Africa NGS Based Diagnostics Market Size by Country (2017-2022)

10.4.2 Middle East & Africa NGS Based Diagnostics Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Janssen

11.1.1 Janssen Company Details

11.1.2 Janssen Business Overview

11.1.3 Janssen NGS Based Diagnostics Introduction

11.1.4 Janssen Revenue in NGS Based Diagnostics Business (2017-2022)

11.1.5 Janssen Recent Developments

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche NGS Based Diagnostics Introduction

11.2.4 Roche Revenue in NGS Based Diagnostics Business (2017-2022)

11.2.5 Roche Recent Developments

11.3 Qiagen

11.3.1 Qiagen Company Details

11.3.2 Qiagen Business Overview

11.3.3 Qiagen NGS Based Diagnostics Introduction

11.3.4 Qiagen Revenue in NGS Based Diagnostics Business (2017-2022)

11.3.5 Qiagen Recent Developments

11.4 ThermoFisher Scientific

11.4.1 ThermoFisher Scientific Company Details

11.4.2 ThermoFisher Scientific Business Overview

11.4.3 ThermoFisher Scientific NGS Based Diagnostics Introduction

11.4.4 ThermoFisher Scientific Revenue in NGS Based Diagnostics Business (2017-2022)

11.4.5 ThermoFisher Scientific Recent Developments

11.5 Oxford Gene Technology

11.5.1 Oxford Gene Technology Company Details

11.5.2 Oxford Gene Technology Business Overview

11.5.3 Oxford Gene Technology NGS Based Diagnostics Introduction

11.5.4 Oxford Gene Technology Revenue in NGS Based Diagnostics Business (2017-2022)

11.5.5 Oxford Gene Technology Recent Developments

11.6 Illumina

11.6.1 Illumina Company Details

11.6.2 Illumina Business Overview

11.6.3 Illumina NGS Based Diagnostics Introduction

11.6.4 Illumina Revenue in NGS Based Diagnostics Business (2017-2022)

11.6.5 Illumina Recent Developments

11.7 Pacific Biosciences

11.7.1 Pacific Biosciences Company Details

11.7.2 Pacific Biosciences Business Overview

11.7.3 Pacific Biosciences NGS Based Diagnostics Introduction

11.7.4 Pacific Biosciences Revenue in NGS Based Diagnostics Business (2017-2022)

11.7.5 Pacific Biosciences Recent Developments

11.8 Paradigm Diagnostics

11.8.1 Paradigm Diagnostics Company Details

11.8.2 Paradigm Diagnostics Business Overview

11.8.3 Paradigm Diagnostics NGS Based Diagnostics Introduction

11.8.4 Paradigm Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022)

11.8.5 Paradigm Diagnostics Recent Developments

11.9 Innogene Kalbiotech

11.9.1 Innogene Kalbiotech Company Details

11.9.2 Innogene Kalbiotech Business Overview

11.9.3 Innogene Kalbiotech NGS Based Diagnostics Introduction

11.9.4 Innogene Kalbiotech Revenue in NGS Based Diagnostics Business (2017-2022)

11.9.5 Innogene Kalbiotech Recent Developments

11.10 Admera Health

11.10.1 Admera Health Company Details

11.10.2 Admera Health Business Overview

11.10.3 Admera Health NGS Based Diagnostics Introduction

11.10.4 Admera Health Revenue in NGS Based Diagnostics Business (2017-2022)

11.10.5 Admera Health Recent Developments

11.11 AITbiotech

11.11.1 AITbiotech Company Details

11.11.2 AITbiotech Business Overview

11.11.3 AITbiotech NGS Based Diagnostics Introduction

11.11.4 AITbiotech Revenue in NGS Based Diagnostics Business (2017-2022)

11.11.5 AITbiotech Recent Developments

11.12 Centogene

11.12.1 Centogene Company Details

11.12.2 Centogene Business Overview

11.12.3 Centogene NGS Based Diagnostics Introduction

11.12.4 Centogene Revenue in NGS Based Diagnostics Business (2017-2022)

11.12.5 Centogene Recent Developments

11.13 Phalanx Biotech Group

11.13.1 Phalanx Biotech Group Company Details

11.13.2 Phalanx Biotech Group Business Overview

11.13.3 Phalanx Biotech Group NGS Based Diagnostics Introduction

11.13.4 Phalanx Biotech Group Revenue in NGS Based Diagnostics Business (2017-2022)

11.13.5 Phalanx Biotech Group Recent Developments

11.14 iGenomX

11.14.1 iGenomX Company Details

11.14.2 iGenomX Business Overview

11.14.3 iGenomX NGS Based Diagnostics Introduction

11.14.4 iGenomX Revenue in NGS Based Diagnostics Business (2017-2022)

11.14.5 iGenomX Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Janssen

Roche

Qiagen NV

ThermoFisher Scientific

Oxford Gene Technology

Illumina Inc

Pacific Biosciences

Paradigm Diagnostics

Innogene Kalbiotech

Admera Health

AITbiotech

CENTOGENE

Phalanx Biotech Group

iGenomX

China

India

List of Tables

Table 1. Global NGS Based Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of DNA Sequencing

Table 3. Key Players of RNA Sequencing

Table 4. Key Players of Whole Genome Sequencing

Table 5. Key Players of Whole Exome Sequencing

Table 6. Key Players of Other

Table 7. Global NGS Based Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 8. Global NGS Based Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 9. Global NGS Based Diagnostics Market Size by Region (2017-2022) & (US$ Million)

Table 10. Global NGS Based Diagnostics Market Share by Region (2017-2022)

Table 11. Global NGS Based Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 12. Global NGS Based Diagnostics Market Share by Region (2023-2028)

Table 13. NGS Based Diagnostics Market Trends

Table 14. NGS Based Diagnostics Market Drivers

Table 15. NGS Based Diagnostics Market Challenges

Table 16. NGS Based Diagnostics Market Restraints

Table 17. Global NGS Based Diagnostics Revenue by Players (2017-2022) & (US$ Million)

Table 18. Global NGS Based Diagnostics Revenue Share by Players (2017-2022)

Table 19. Global Top NGS Based Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS Based Diagnostics as of 2021)

Table 20. Ranking of Global Top NGS Based Diagnostics Companies by Revenue (US$ Million) in 2021

Table 21. Global 5 Largest Players Market Share by NGS Based Diagnostics Revenue (CR5 and HHI) & (2017-2022)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players NGS Based Diagnostics Product Solution and Service

Table 24. Date of Enter into NGS Based Diagnostics Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global NGS Based Diagnostics Market Size by Type (2017-2022) & (US$ Million)

Table 27. Global NGS Based Diagnostics Revenue Market Share by Type (2017-2022)

Table 28. Global NGS Based Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 29. Global NGS Based Diagnostics Revenue Market Share by Type (2023-2028)

Table 30. Global NGS Based Diagnostics Market Size by Application (2017-2022) & (US$ Million)

Table 31. Global NGS Based Diagnostics Revenue Share by Application (2017-2022)

Table 32. Global NGS Based Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 33. Global NGS Based Diagnostics Revenue Share by Application (2023-2028)

Table 34. North America NGS Based Diagnostics Market Size by Type (2017-2022) & (US$ Million)

Table 35. North America NGS Based Diagnostics Market Size by Type (2023-2028) & (US$ Million)

Table 36. North America NGS Based Diagnostics Market Size by Application (2017-2022) & (US$ Million)

Table 37. North America NGS Based Diagnostics Market Size by Application (2023-2028) & (US$ Million)

Table 38. North America NGS Based Diagnostics Market Size by Country (2017-2022) & (US$ Million)

Table 39. North America NGS Based Diagnostics Market Size by Country (2023-2028) & (US$ Million)

Table 40. Europe NGS Based Diagnostics Market Size by Type (2017-2022) & (US$ Million)

Table 41. Europe NGS Based Diagnostics Market Size by Type (2023-2028) & (US$ Million)

Table 42. Europe NGS Based Diagnostics Market Size by Application (2017-2022) & (US$ Million)

Table 43. Europe NGS Based Diagnostics Market Size by Application (2023-2028) & (US$ Million)

Table 44. Europe NGS Based Diagnostics Market Size by Country (2017-2022) & (US$ Million)

Table 45. Europe NGS Based Diagnostics Market Size by Country (2023-2028) & (US$ Million)

Table 46. Asia Pacific NGS Based Diagnostics Market Size by Type (2017-2022) & (US$ Million)

Table 47. Asia Pacific NGS Based Diagnostics Market Size by Type (2023-2028) & (US$ Million)

Table 48. Asia Pacific NGS Based Diagnostics Market Size by Application (2017-2022) & (US$ Million)

Table 49. Asia Pacific NGS Based Diagnostics Market Size by Application (2023-2028) & (US$ Million)

Table 50. Asia Pacific NGS Based Diagnostics Market Size by Region (2017-2022) & (US$ Million)

Table 51. Asia Pacific NGS Based Diagnostics Market Size by Region (2023-2028) & (US$ Million)

Table 52. Latin America NGS Based Diagnostics Market Size by Type (2017-2022) & (US$ Million)

Table 53. Latin America NGS Based Diagnostics Market Size by Type (2023-2028) & (US$ Million)

Table 54. Latin America NGS Based Diagnostics Market Size by Application (2017-2022) & (US$ Million)

Table 55. Latin America NGS Based Diagnostics Market Size by Application (2023-2028) & (US$ Million)

Table 56. Latin America NGS Based Diagnostics Market Size by Country (2017-2022) & (US$ Million)

Table 57. Latin America NGS Based Diagnostics Market Size by Country (2023-2028) & (US$ Million)

Table 58. Middle East and Africa NGS Based Diagnostics Market Size by Type (2017-2022) & (US$ Million)

Table 59. Middle East and Africa NGS Based Diagnostics Market Size by Type (2023-2028) & (US$ Million)

Table 60. Middle East and Africa NGS Based Diagnostics Market Size by Application (2017-2022) & (US$ Million)

Table 61. Middle East and Africa NGS Based Diagnostics Market Size by Application (2023-2028) & (US$ Million)

Table 62. Middle East and Africa NGS Based Diagnostics Market Size by Country (2017-2022) & (US$ Million)

Table 63. Middle East and Africa NGS Based Diagnostics Market Size by Country (2023-2028) & (US$ Million)

Table 64. Janssen Company Details

Table 65. Janssen Business Overview

Table 66. Janssen NGS Based Diagnostics Product

Table 67. Janssen Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)

Table 68. Janssen Recent Developments

Table 69. Roche Company Details

Table 70. Roche Business Overview

Table 71. Roche NGS Based Diagnostics Product

Table 72. Roche Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)

Table 73. Roche Recent Developments

Table 74. Qiagen Company Details

Table 75. Qiagen Business Overview

Table 76. Qiagen NGS Based Diagnostics Product

Table 77. Qiagen Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)

Table 78. Qiagen Recent Developments

Table 79. ThermoFisher Scientific Company Details

Table 80. ThermoFisher Scientific Business Overview

Table 81. ThermoFisher Scientific NGS Based Diagnostics Product

Table 82. ThermoFisher Scientific Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)

Table 83. ThermoFisher Scientific Recent Developments

Table 84. Oxford Gene Technology Company Details

Table 85. Oxford Gene Technology Business Overview

Table 86. Oxford Gene Technology NGS Based Diagnostics Product

Table 87. Oxford Gene Technology Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)

Table 88. Oxford Gene Technology Recent Developments

Table 89. Illumina Company Details

Table 90. Illumina Business Overview

Table 91. Illumina NGS Based Diagnostics Product

Table 92. Illumina Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)

Table 93. Illumina Recent Developments

Table 94. Pacific Biosciences Company Details

Table 95. Pacific Biosciences Business Overview

Table 96. Pacific Biosciences NGS Based Diagnostics Product

Table 97. Pacific Biosciences Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)

Table 98. Pacific Biosciences Recent Developments

Table 99. Paradigm Diagnostics Company Details

Table 100. Paradigm Diagnostics Business Overview

Table 101. Paradigm Diagnostics NGS Based Diagnostics Product

Table 102. Paradigm Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)

Table 103. Paradigm Diagnostics Recent Developments

Table 104. Innogene Kalbiotech Company Details

Table 105. Innogene Kalbiotech Business Overview

Table 106. Innogene Kalbiotech NGS Based Diagnostics Product

Table 107. Innogene Kalbiotech Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)

Table 108. Innogene Kalbiotech Recent Developments

Table 109. Admera Health Company Details

Table 110. Admera Health Business Overview

Table 111. Admera Health NGS Based Diagnostics Product

Table 112. Admera Health Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)

Table 113. Admera Health Recent Developments

Table 114. AITbiotech Company Details

Table 115. AITbiotech Business Overview

Table 116. AITbiotech NGS Based Diagnostics Product

Table 117. AITbiotech Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)

Table 118. AITbiotech Recent Developments

Table 119. Centogene Company Details

Table 120. Centogene Business Overview

Table 121. Centogene NGS Based Diagnostics Product

Table 122. Centogene Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)

Table 123. Centogene Recent Developments

Table 124. Phalanx Biotech Group Company Details

Table 125. Phalanx Biotech Group Business Overview

Table 126. Phalanx Biotech Group NGS Based Diagnostics Product

Table 127. Phalanx Biotech Group Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)

Table 128. Phalanx Biotech Group Recent Developments

Table 129. iGenomX Company Details

Table 130. iGenomX Business Overview

Table 131. iGenomX NGS Based Diagnostics Product

Table 132. iGenomX Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)

Table 133. iGenomX Recent Developments

Table 134. Research Programs/Design for This Report

Table 135. Key Data Information from Secondary Sources

Table 136. Key Data Information from Primary Sources

List of Figures

Figure 1. Global NGS Based Diagnostics Market Share by Type: 2021 VS 2028

Figure 2. DNA Sequencing Features

Figure 3. RNA Sequencing Features

Figure 4. Whole Genome Sequencing Features

Figure 5. Whole Exome Sequencing Features

Figure 6. Other Features

Figure 7. Global NGS Based Diagnostics Market Share by Application: 2021 VS 2028

Figure 8. Hospitals Case Studies

Figure 9. Clinics Case Studies

Figure 10. Academics/Research Institutions Case Studies

Figure 11. NGS Based Diagnostics Report Years Considered

Figure 12. Global NGS Based Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 13. Global NGS Based Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 14. Global NGS Based Diagnostics Market Share by Region: 2021 VS 2028

Figure 15. Global NGS Based Diagnostics Market Share by Players in 2021

Figure 16. Global Top NGS Based Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS Based Diagnostics as of 2021)

Figure 17. The Top 10 and 5 Players Market Share by NGS Based Diagnostics Revenue in 2021

Figure 18. North America NGS Based Diagnostics Market Size YoY (2017-2028) & (US$ Million)

Figure 19. North America NGS Based Diagnostics Market Size Market Share by Type (2017-2028)

Figure 20. North America NGS Based Diagnostics Market Size Market Share by Application (2017-2028)

Figure 21. North America NGS Based Diagnostics Market Size Share by Country (2017-2028)

Figure 22. United States NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 23. Canada NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 24. Europe NGS Based Diagnostics Market Size YoY (2017-2028) & (US$ Million)

Figure 25. Europe NGS Based Diagnostics Market Size Market Share by Type (2017-2028)

Figure 26. Europe NGS Based Diagnostics Market Size Market Share by Application (2017-2028)

Figure 27. Europe NGS Based Diagnostics Market Size Share by Country (2017-2028)

Figure 28. Germany NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. France NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. U.K. NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Italy NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Russia NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. Nordic Countries NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 34. Asia-Pacific NGS Based Diagnostics Market Size YoY (2017-2028) & (US$ Million)

Figure 35. Asia Pacific NGS Based Diagnostics Market Size Market Share by Type (2017-2028)

Figure 36. Asia Pacific NGS Based Diagnostics Market Size Market Share by Application (2017-2028)

Figure 37. Asia Pacific NGS Based Diagnostics Market Size Share by Region (2017-2028)

Figure 38. China NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. Japan NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. South Korea NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. Southeast Asia NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 42. India NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 43. Australia NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 44. Latin America NGS Based Diagnostics Market Size YoY (2017-2028) & (US$ Million)

Figure 45. Latin America NGS Based Diagnostics Market Size Market Share by Type (2017-2028)

Figure 46. Latin America NGS Based Diagnostics Market Size Market Share by Application (2017-2028)

Figure 47. Latin America NGS Based Diagnostics Market Size Share by Country (2017-2028)

Figure 48. Mexico NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 49. Brazil NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 50. Middle East & Africa NGS Based Diagnostics Market Size YoY (2017-2028) & (US$ Million)

Figure 51. Middle East and Africa NGS Based Diagnostics Market Size Market Share by Type (2017-2028)

Figure 52. Middle East and Africa NGS Based Diagnostics Market Size Market Share by Application (2017-2028)

Figure 53. Middle East and Africa NGS Based Diagnostics Market Size Share by Country (2017-2028)

Figure 54. Turkey NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 55. Saudi Arabia NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 56. UAE NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 57. Janssen Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)

Figure 58. Roche Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)

Figure 59. Qiagen Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)

Figure 60. ThermoFisher Scientific Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)

Figure 61. Oxford Gene Technology Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)

Figure 62. Illumina Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)

Figure 63. Pacific Biosciences Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)

Figure 64. Paradigm Diagnostics Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)

Figure 65. Innogene Kalbiotech Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)

Figure 66. Admera Health Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)

Figure 67. AITbiotech Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)

Figure 68. Centogene Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)

Figure 69. Phalanx Biotech Group Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)

Figure 70. iGenomX Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global NGS Based Diagnostics Market Insights and Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-9T1976

Global NGS Based Diagnostics Market Insights and Forecast to 2028

FEATURED COMPANIES

NGS Based Diagnostics Market

By Type

By Application

Key Type

By Region

FEATURED COMPANIES

RELATED REPORTS